Ipca Laboratories Limited is a leading Indian pharmaceutical company engaged in the manufacturing and marketing of active pharmaceutical ingredients (APIs), branded formulations, and generic medicines. Established in 1949, the company has built a significant presence across more than 120 countries through its diversified product portfolio and vertically integrated manufacturing capabilities. Ipca specializes in anti-malarials, pain management, cardiovascular, diabetes, rheumatology, and gastroenterology therapies while maintaining a strong position in API production for global markets. The company operates multiple manufacturing facilities that meet stringent international regulatory standards and invests consistently in research and product development. Ipca continues to expand its domestic branded formulations business alongside its export operations in regulated and emerging markets. By combining high-quality manufacturing, process innovation, and affordable healthcare solutions, the company has established itself as one of India’s leading pharmaceutical exporters and a trusted supplier to healthcare systems worldwide.
NSE: IPCALAB | BSE: 524494
Mumbai, Maharashtra, India
~16,000 employees
